Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Man Jiang

Showing results (401-410 of 412) with videos related to

Pageof 42
Sort By:
Molecular Neurodegeneration|January 11, 2022
A novel H129-based anterograde monosynaptic tracer exhibits features of strong labeling intensity, high tracing efficiency, and reduced retrograde labelingHong Yang, Feng Xiong, Hai-Bin Qin, et al.
Science Translational Medicine|June 30, 2017
Genetic and epigenetic inactivation of <i>SESTRIN1</i> controls mTORC1 and response to EZH2 inhibition in follicular lymphomaElisa Oricchio, Natalya Katanayeva, Maria Christine Donaldson, et al.
Cell|November 1, 2011
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphomaElisa Oricchio, Gouri Nanjangud, Andrew L Wolfe, et al.
Cell|October 4, 2016
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T CellsMichael Boice, Darin Salloum, Frederic Mourcin, et al.
Signal Transduction and Targeted Therapy|September 10, 2025
Loss-of-function variations in solute carrier family 38 member 6 are associated with essential tremorZhangqi Yuan, Qiying Sun, Junyu Luo, et al.
Nature|August 1, 2014
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancerAndrew L Wolfe, Kamini Singh, Yi Zhong, et al.
Science (New York, N.Y.)|November 16, 2023
A tool kit of highly selective and sensitive genetically encoded neuropeptide sensorsHuan Wang, Tongrui Qian, Yulin Zhao, et al.
Cancer Research|February 26, 2021
Targeting eIF4A-Dependent Translation of KRAS Signaling MoleculesKamini Singh, Jianan Lin, Nicolas Lecomte, et al.
Nature Medicine|September 15, 2015
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma developmentAna Ortega-Molina, Isaac W Boss, Andres Canela, et al.
Nature Cancer|February 11, 2021
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencingSara Parsa, Ana Ortega-Molina, Hsia-Yuan Ying, et al.
Pageof 42

Showing results (401-410 of 412) with videos related to

Sort By:
Pageof 42
Molecular Neurodegeneration|January 11, 2022
A novel H129-based anterograde monosynaptic tracer exhibits features of strong labeling intensity, high tracing efficiency, and reduced retrograde labelingHong Yang, Feng Xiong, Hai-Bin Qin, et al.
Science Translational Medicine|June 30, 2017
Genetic and epigenetic inactivation of <i>SESTRIN1</i> controls mTORC1 and response to EZH2 inhibition in follicular lymphomaElisa Oricchio, Natalya Katanayeva, Maria Christine Donaldson, et al.
Cell|November 1, 2011
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphomaElisa Oricchio, Gouri Nanjangud, Andrew L Wolfe, et al.
Cell|October 4, 2016
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T CellsMichael Boice, Darin Salloum, Frederic Mourcin, et al.
Signal Transduction and Targeted Therapy|September 10, 2025
Loss-of-function variations in solute carrier family 38 member 6 are associated with essential tremorZhangqi Yuan, Qiying Sun, Junyu Luo, et al.
Nature|August 1, 2014
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancerAndrew L Wolfe, Kamini Singh, Yi Zhong, et al.
Science (New York, N.Y.)|November 16, 2023
A tool kit of highly selective and sensitive genetically encoded neuropeptide sensorsHuan Wang, Tongrui Qian, Yulin Zhao, et al.
Cancer Research|February 26, 2021
Targeting eIF4A-Dependent Translation of KRAS Signaling MoleculesKamini Singh, Jianan Lin, Nicolas Lecomte, et al.
Nature Medicine|September 15, 2015
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma developmentAna Ortega-Molina, Isaac W Boss, Andres Canela, et al.
Nature Cancer|February 11, 2021
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencingSara Parsa, Ana Ortega-Molina, Hsia-Yuan Ying, et al.
Pageof 42